Originally posted in PR Rocket on July 31, 2015
With the advancement of sleep apnea treatment technology, OravanOSA has introduced its FDA cleared Mandibular Advancement Device, aimed to move the jaw forward, further opening the upper airway for easy breathing.
West Orange, NJ (PRWEB) July 31, 2015
With the recent buzz surrounding the dangers of obstructive sleep apnea (OSA) and the growing number of individuals who remain undiagnosed, treatment options for patients are becoming more prevalent than ever before. As millions of Americans continue to shy away from traditional CPAP therapy due to its overall lack of comfort and highly invasive nature, oral appliances provided by dentists are gaining extreme popularity.
Mandibular Advancement Devices (MADs) move the lower jaw forward further opening the upper airway to allow for easy breathing. Of the many MADs on the market today, the Oravan device, manufactured by OravanOSA, has captured the attention of many in the sleep industry.Read More
Originally posted in Medgadget on JULY 24TH, 2015 RADIANT INSIGHTS, INC.
Global Markets Direct’s, ‘Sleep Apnea – Pipeline Review, H2 2014′, provides an overview of the Sleep Apnea’s therapeutic pipeline.
This report provides comprehensive information on the therapeutic development for Sleep Apnea, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases.
It also reviews key players involved in the therapeutic development for Sleep Apnea and special features on late-stage and discontinued projects.
To Get More Details @http://www.radiantinsights.com/research/sleep-apnea-pipeline-review-h2-2014
Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team.Read More
Below is a snippet of a study that was completed to try and predict who was going to become a compliant CPAP user based on information from their sleep study.
Extensive use of continuous positive airway pressure (CPAP) has positive clinical benefits for most patients with obstructive sleep apnea (OSA). However, patient adherence is a major limiting factor to the effectiveness of CPAP treatment. This study determined the potential factors affecting the willingness of patients with OSA to undertake CPAP treatment by comparing the polysomnographic parameters (Sleep Study) recorded during diagnosis (without CPAP) and titration (with CPAP). A total of 312 patients who were diagnosed with moderate and severe OSA, were divided into persistent users and nonusers of CPAP according to their use of in-home CPAP during a 7-day CPAP trial. Among the patients, 146 (46.8%) became persistent CPAP users. A 10% improvement of oxygen desaturation index (ODI) and a 10% increment in deep sleep percentage increased the chance of persistent CPAP use. Read More
A common therapy to tackle obstructive sleep apnea (OSA) does not become a hindrance between the sheets, says a study, allaying fears of OSA patients who believe the therapy interferes with sex.
Erectile Dysfunction (ED) is somewhat common in patients with OSA who are often recommended to use a continuous positive airway pressure (CPAP) mask to get rid of the ED symptoms.
The machine uses a constant flow of positive air pressure to ensure the wearer gets adequate oxygen.
“However, some patients may feel that the PAP interferes with foreplay and sex,” the study said.
For their research, the team from Rosalind Franklin University in Chicago analysed 52 participants who were screened about their sex life, compliance of PAP use, body mass index (BMI), presence of ED and use of drugs like Viagra.
Results showed that when adjusting for all confounding variables, CPAP compliance does not predict sexual quality of life.Read More
Posted: 10:29 a.m. Monday, June 16, 2014
PITTSBURGH —Read More